Home
News
In Focus
Business
Metro
Nation
World
Sports
Feature
Opinion
View more »Opinion Columns
Wan LixinOpinion deputy editor of Shanghai Daily
Restaurants get off to a quick start thanks to game-changing policies
High service charges on event ticket refunds call for further regulation
Sunday
- Subscribe
Home » Business » Manufacturing
Sinopharm to list in Hong Kong
By Fion Li |
July 30, 2009, Thursday
|
Print Edition
Print Edition
SINOPHARM Holdings, majority owned by state-run China National Pharmaceutical Group, has been granted approval by Chinese officials to list in Hong Kong, sources said yesterday, in an IPO that could raise up to 7 billion yuan (US$1.03 billion).
The parent company plans to list drug distributor Sinopharm in September and is waiting for the Hong Kong Exchange's approval, said the banking sources.
Shanghai Fosun Pharmaceutical, a unit of Hong Kong's Fosun International, owns 47 percent of Sinopharm, according to a spokeswoman for Fosun International.
UBS AG, CICC and Morgan Stanley are among the banks handling the offering, the sources said.
China National Pharmaceutical Group Corp is China's largest pharmaceutical group, incorporating research with production and in charge of national reserves and the allocation and supply of emergency and relief medicines.
Sinopharm Holdings is the largest distributor in the Chinese pharmaceutical market. It owns majority stakes in China National Medicines and Shenzhen Accord Pharmaceutical.
The parent company plans to list drug distributor Sinopharm in September and is waiting for the Hong Kong Exchange's approval, said the banking sources.
Shanghai Fosun Pharmaceutical, a unit of Hong Kong's Fosun International, owns 47 percent of Sinopharm, according to a spokeswoman for Fosun International.
UBS AG, CICC and Morgan Stanley are among the banks handling the offering, the sources said.
China National Pharmaceutical Group Corp is China's largest pharmaceutical group, incorporating research with production and in charge of national reserves and the allocation and supply of emergency and relief medicines.
Sinopharm Holdings is the largest distributor in the Chinese pharmaceutical market. It owns majority stakes in China National Medicines and Shenzhen Accord Pharmaceutical.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
